Research Database

11 studies found

Positive

90.9%

Negative

0.0%

Inconclusive

9.1%

Page 1 of 1

PositiveDouble Blind Clinical Trial

Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity-A Randomized, Double-Blind Clinical Trial

2024

Insomnia and Sleep DisordersPainTemporomandibular Disorders

InconclusiveMeta-analysis -

Cannabinoid therapeutics in orofacial pain management: a systematic review

2022

Cancer

PositiveMeta-analysis -

Efficacy of topical interventions for temporomandibular disorders compared to placebo or control therapy: a systematic review with meta-analysis

2020

Temporomandibular Disorders

PositiveAnimal Study -

Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain

2019

Temporomandibular Disorders

PositiveDouble Blind Clinical Trial

Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial

2019

Pain

PositiveReview/Other

Micronized palmitoylethanolamide reduces joint pain and glial cell activation

2018

Temporomandibular Disorders

PositiveAnimal Study - Veterinary Clinical Trial

Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation

2017

Temporomandibular Disorders

PositiveReview/Other

Effects of two different specific neck exercise interventions on palmitoylethanolamide and stearoylethanolamide concentrations in the interstitium of the trapezius muscle in women with chronic neck shoulder pain

2014

Pain

PositiveReview/Other

Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests

2010

Temporomandibular Disorders

PositiveAnimal Study -

Low doses of cannabinoids enhance the antinociceptive effects of intracisternally-administered mGluRs groups II and III agonists in formalin-induced TMJ nociception in rats

2008

Temporomandibular Disorders

PositiveReview/Other

Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception

2007

Temporomandibular Disorders

Command Palette

Research Database

Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity-A Randomized, Double-Blind Clinical Trial

Cannabinoid therapeutics in orofacial pain management: a systematic review

Efficacy of topical interventions for temporomandibular disorders compared to placebo or control therapy: a systematic review with meta-analysis

Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain

Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial

Micronized palmitoylethanolamide reduces joint pain and glial cell activation

Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation

Effects of two different specific neck exercise interventions on palmitoylethanolamide and stearoylethanolamide concentrations in the interstitium of the trapezius muscle in women with chronic neck shoulder pain

Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests

Low doses of cannabinoids enhance the antinociceptive effects of intracisternally-administered mGluRs groups II and III agonists in formalin-induced TMJ nociception in rats

Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception